Clinical Trial

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Study acronym: GSI
Recruiting
View on ClinicalTrials.gov →
Summary
Individuals with suspected primary immunodeficiency will be studied and the results compared with healthy controls. Primary immunodeficiency may manifest as recurrent, severe or unusual infections as well as signs and symptoms of immune dysregulation such as autoimmunity or lymphoproliferation.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2016-04-07; most recent amendment 2026-05-11.
Trial Details
NCT Number NCT02735824
Lead Sponsor University Children's Hospital, Zurich
Conditions Immunologic Deficiency Syndromes, Primary Immune Deficiency (PID)
Enrollment 500 participants
Start Date 2016-02
Primary Completion 2027-07 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-14